{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:39Z","timestamp":1791233139075,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272949"],"award-info":[{"award-number":["82272949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473558"],"award-info":[{"award-number":["82473558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471587"],"award-info":[{"award-number":["82471587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116659","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:08:30Z","timestamp":1776330510000},"page":"116659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Keratinocyte-derived exosomal miR-31-5p reduces vemurafenib sensitivity in melanoma cells"],"prefix":"10.1016","volume":"179","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongying","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.intimp.2026.116659_bb0005","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the american joint committee on cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.116659_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OTT.S39096","article-title":"BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies","volume":"8","author":"Spagnolo","year":"2015","journal-title":"Onco. Targets Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","article-title":"The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov."},{"issue":"20","key":"10.1016\/j.intimp.2026.116659_bb0020","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116659_bb0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molcel.2015.06.028","article-title":"Interactions of melanoma cells with distal keratinocytes trigger metastasis via notch signaling inhibition of MITF","volume":"59","author":"Golan","year":"2015","journal-title":"Mol. Cell"},{"issue":"50","key":"10.1016\/j.intimp.2026.116659_bb0030","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1038\/s41388-019-0961-9","article-title":"The dysfunction of BP180\/collagen XVII in keratinocytes promotes melanoma progression","volume":"38","author":"Hwang","year":"2019","journal-title":"Oncogene"},{"issue":"7490","key":"10.1016\/j.intimp.2026.116659_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature13111","article-title":"Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma","volume":"507","author":"Bald","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2026.116659_bb0040","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1158\/0008-5472.CAN-18-3134","article-title":"Upregulation of PD-L1 via HMGB1-activated IRF3 and NF-kappaB contributes to UV radiation-induced immune suppression","volume":"79","author":"Wang","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116659_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051297","article-title":"Tspan8 drives melanoma dermal invasion by promoting ProMMP-9 activation and basement membrane proteolysis in a keratinocyte-dependent manner","volume":"12","author":"El Kharbili","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2026.116659_bb0050","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2013.32","article-title":"Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas","volume":"133","author":"Liu","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.116659_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8506","article-title":"Exosomes released by keratinocytes modulate melanocyte pigmentation","volume":"6","author":"Lo Cicero","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.116659_bb0060","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/jid.2013.478","article-title":"Reduced MiR-675 in exosome in h19 RNA-related melanogenesis via MITF as a direct target","volume":"134","author":"Kim","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"29","key":"10.1016\/j.intimp.2026.116659_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1705206114","article-title":"BRAF(V600) inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells","volume":"114","author":"Lunavat","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0070","doi-asserted-by":"crossref","first-page":"14197","DOI":"10.1038\/s41598-019-50732-w","article-title":"Targeting CDC7 sensitizes resistance melanoma cells to BRAF(V600E)-specific inhibitor by blocking the CDC7\/MCM2-7 pathway","volume":"9","author":"Gad","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116659_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155410","article-title":"Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway","volume":"260","author":"Luan","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.intimp.2026.116659_bb0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15384047.2016.1250987","article-title":"Suppression of B-Raf(V600E) melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone","volume":"18","author":"Hong","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2026.116659_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123108","article-title":"Exosomes from human bone marrow MSCs alleviate PD-1\/PD-L1 inhibitor-induced myocardial injury in melanoma mice by regulating macrophage polarization and pyroptosis","volume":"358","author":"Zhou","year":"2024","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.116659_bb0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41419-023-06007-4","article-title":"Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1","volume":"14","author":"Luo","year":"2023","journal-title":"Cell Death Dis."},{"issue":"W1","key":"10.1016\/j.intimp.2026.116659_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz479","article-title":"RNAmod: an integrated system for the annotation of mRNA modifications","volume":"47","author":"Liu","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116659_bb0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CMR.0000000000000580","article-title":"RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2","volume":"29","author":"Dahal","year":"2019","journal-title":"Melanoma Res."},{"key":"10.1016\/j.intimp.2026.116659_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2021.09.015","article-title":"METTL3 induces PLX4032 resistance in melanoma by promoting m(6)A-dependent EGFR translation","volume":"522","author":"Bhattarai","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116659_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114284","article-title":"ALKBH1 promotes lung cancer by regulating m6A RNA demethylation","volume":"189","author":"Li","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13046-018-0911-3","article-title":"Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway","volume":"37","author":"Zhou","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.116659_bb0120","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41419-021-04378-0","article-title":"P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells","volume":"12","author":"Pegoraro","year":"2021","journal-title":"Cell Death Dis."},{"issue":"42","key":"10.1016\/j.intimp.2026.116659_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz4530","article-title":"Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation","volume":"6","author":"Aiello","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.116659_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115554","article-title":"ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK\/mTOR pathway in melanoma","volume":"212","author":"Wang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116659_bb0135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63093","article-title":"MITF reprograms the extracellular matrix and focal adhesion in melanoma","volume":"10","author":"Dilshat","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41392-023-01329-3","article-title":"Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1\/2","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0145","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1038\/s41467-022-31399-w","article-title":"Inactivation of the hippo tumor suppressor pathway promotes melanoma","volume":"13","author":"Vittoria","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2026.116659_bb0150","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.18632\/aging.101520","article-title":"Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p\/RAB27A axis","volume":"10","author":"Bi","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"10.1016\/j.intimp.2026.116659_bb0155","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.7150\/thno.42371","article-title":"PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating wnt\/beta-catenin signaling and homologous recombination","volume":"10","author":"Wen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.116659_bb0160","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.2147\/CMAR.S247780","article-title":"MiR-31-5p regulates 14-3-3 varepsilon to inhibit prostate cancer 22RV1 cell survival and proliferation via PI3K\/AKT\/Bcl-2 signaling pathway","volume":"12","author":"Zhao","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116659_bb0165","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7150\/thno.22059","article-title":"MiR-31-5p-ACOX1 axis enhances tumorigenic fitness in oral squamous cell carcinoma via the promigratory prostaglandin e2","volume":"8","author":"Lai","year":"2018","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.intimp.2026.116659_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101576","article-title":"FOXC1 regulation of miR-31-5p confers oxaliplatin resistance by targeting LATS2 in colorectal cancer","volume":"11","author":"Hsu","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"3","key":"10.1016\/j.intimp.2026.116659_bb0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41422-020-00397-2","article-title":"Oncogenic AURKA-enhanced n(6)-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells","volume":"31","author":"Peng","year":"2021","journal-title":"Cell Res."},{"issue":"20","key":"10.1016\/j.intimp.2026.116659_bb0180","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104514","article-title":"M(6) a RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy","volume":"39","author":"Wang","year":"2020","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0185","article-title":"M(6)a mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.intimp.2026.116659_bb0190","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.intimp.2026.116659_bb0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/1878-0261.13366","article-title":"ALKBH1-mediated m(1) a demethylation of METTL3 mRNA promotes the metastasis of colorectal cancer by downregulating SMAD7 expression","volume":"17","author":"Chen","year":"2023","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116659_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13986","article-title":"ALKBH1 contributes to renal cell carcinoma progression by reducing n6-methyladenine of GPR137","volume":"53","author":"Li","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.62347\/ALXR1853","article-title":"ALKBH1-mediated n6-methyladenosine methylation of TRAF1 promotes osteosarcoma proliferation and metastasis","volume":"15","author":"Wang","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.116659_bb0210","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201912074","article-title":"The RNA binding protein FMR1 controls selective exosomal miRNA cargo loading during inflammation","volume":"219","author":"Wozniak","year":"2020","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169237","article-title":"Defining transcriptional regulatory mechanisms for primary let-7 miRNAs","volume":"12","author":"Gaeta","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41556-020-00606-5","article-title":"Phase separation of SERRATE drives dicing body assembly and promotes miRNA processing in arabidopsis","volume":"23","author":"Xie","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116659_bb0225","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/0008-5472.CAN-17-1318","article-title":"MiR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma","volume":"78","author":"Diaz-Martinez","year":"2018","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.116659_bb0230","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/exd.14001","article-title":"Evidence on the direct correlation between miR-31 and IL-22 axis in IMQ-induced psoriasis","volume":"28","author":"Abdallah","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2026.116659_bb0235","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2026.116659_bb0240","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/CMR.0000000000000546","article-title":"Vemurafenib impairs the repair of ultraviolet radiation-induced DNA damage","volume":"29","author":"Kimeswenger","year":"2019","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116659_bb0245","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2020.06.016","article-title":"Exosome-containing preparations from postirradiated mouse melanoma cells delay melanoma growth in vivo by a natural killer cell-dependent mechanism","volume":"108","author":"Jella","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:56:39Z","timestamp":1778820999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926005047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S1567576926005047"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116659","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keratinocyte-derived exosomal miR-31-5p reduces vemurafenib sensitivity in melanoma cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116659"}}